This Week in PLOS

In PLOS One, Translational Genomics Research Institute researcher Daniel Von Hoff and his colleagues describe findings from a whole-genome sequencing study of pancreatic cancer. The group, which included investigators from TGen, Scottsdale's Mayo Clinic, the Virginia G. Piper Cancer Center Clinical Trials, and Arizona State University, sequenced matched tumor and normal samples from three individuals with pancreatic adenocarcinoma.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in PLOS

This Week in PLOS

This Week in PNAS

This Week in PLOS

This Week in PLOS

This Week in PLOS

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.